PATENT CLAIM ANALYSIS

Application Number: 15865963
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "094000"]

Abstract:
The present invention discloses compounds according to Formula I: wherein R 1  is as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment cystic fibrosis by administering a compound of the invention.

Claim (Index 11):
A method according to  claim 1 , wherein R 1  is \u2014CH 3 , \u2014CH 2 \u2014CH 3 , \u2014CH(CH 3 ) 2 , \u2014C(CH 3 ) 3 , \u2014C(CH 3 ) 2 \u2014CH 3 , or \u2014C(CH 3 )H\u2014CH(CH 3 ) 2 , each of which is substituted with one or more independently selected R 4  groups.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 86.0
- Lexical Diversity: 1.475
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14808200', '14451619', '15143967', '15843917', '15164317']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8228021724242058
- 35 USC 102 Novelty (BERT): 0.6176008457008298
- Combined Prediction Score: 0.8022820397518683
- Mean Citation Score: 514.236832
- Max Citation Score: 581.739
- Similarity Product: 487.2863576731682

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test